2022
DOI: 10.1016/j.gene.2021.146019
|View full text |Cite
|
Sign up to set email alerts
|

Glutathione-S-transferase genetic polymorphism and risk of hepatotoxicity to antitubercular drugs in a North-African population: A case-control study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 46 publications
0
1
0
Order By: Relevance
“…Homozygosity of GSTT1 or GSTM1 null genotypes cause lack of enzyme activity thus leading to the accumulation of the toxic intermediates of Isoniazid metabolisms and hepatotoxins. A statistically significant association between GSTM1 and GSTT1 double null genotypes, and the risk of anti-tubercular drug hepatotxicity was found (p = 0.033) between cases and controls 70 . This genetic variable could be used to develop a pharmacokinetic model of isoniazid concentration in order to maximize the probability of achieving its desired therapeutic concentration and avoid it toxicity in the Tunisian population 71 .…”
Section: Discussionmentioning
confidence: 92%
“…Homozygosity of GSTT1 or GSTM1 null genotypes cause lack of enzyme activity thus leading to the accumulation of the toxic intermediates of Isoniazid metabolisms and hepatotoxins. A statistically significant association between GSTM1 and GSTT1 double null genotypes, and the risk of anti-tubercular drug hepatotxicity was found (p = 0.033) between cases and controls 70 . This genetic variable could be used to develop a pharmacokinetic model of isoniazid concentration in order to maximize the probability of achieving its desired therapeutic concentration and avoid it toxicity in the Tunisian population 71 .…”
Section: Discussionmentioning
confidence: 92%